Galena Biopharma (NASDAQ:GALE) was downgraded by Cantor Fitzgerald from a “buy” rating to a “sell” rating in a research note issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $3.50 price target on the stock. Cantor Fitzgerald’s target price would suggest a potential downside of 6.17% from the stock’s previous close. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $3.47 in last trading session, and closed at $3.79, trading in the range of $3.26 – $3.93. The stock showed a negative weekly performance of -29.68%.
Renren Inc (NYSE:RENN) average recommendation is underweight with average Target Price of $2.97. Renren Inc (NYSE:RENN) shares closed at $3.76 on last trade day, by gaining 11.24%. Stock 52 week range is $2.52 – $4.62. Company’s market capitalization is $1.40 billion.
ReneSola (NYSE:SOL) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued to investors on Thursday, American Banking News.com reports. They currently have a $3.25 price target on the stock. Zacks‘ price target indicates a potential upside of 0.93% from the stock’s previous close. ReneSola Ltd. (ADR) (NYSE:SOL) stock advanced 8.81% and finished the last session at $3.58. The EPS of the stock remained -3.96. Company’s market capitalization is $309.26 million.
Questcor Pharmaceuticals (NASDAQ:QCOR) declared a quarterly dividend on Friday, February 14th, American Banking & Market News reports. Investors of record on Friday, April 18th will be given a dividend of 0.30 per share on Friday, April 25th. This represents a $1.20 dividend on an annualized basis and a yield of 1.73%. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stock opened at $70.37 in last trading session and closed at $75.83. The 52 week range of the stock is $26.80 – $76.46 and the day range was $69.73 – $76.46.
Leave a Reply